Paralysis Global Clinical Trials Review, H1, 2014

Publisher Name:
Published Date: 20-Jun-2014
No. of pages: 76

GlobalData’s clinical trial report, “Paralysis Global Clinical Trials Review, H1, 2014″ provides data on the Paralysis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Paralysis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Paralysis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents For This Report

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Paralysis 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Paralysis to Central Nervous System Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Paralysis to Central Nervous System Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Paralysis 25

Subjects Recruited Over a Period of Time 27

Clinical Trials by Sponsor Type 28

Prominent Sponsors 29

Top Companies Participating in Paralysis Therapeutics Clinical Trials 30

Prominent Drugs 31

Clinical Trial Profiles 32

Clinical Trial Overview of Top Companies 32

Stemedica Cell Technologies, Inc. 32

Clinical Trial Overview of Stemedica Cell Technologies, Inc. 32

Teva Pharmaceutical Industries Limited 33

Clinical Trial Overview of Teva Pharmaceutical Industries Limited 33

Teijin Limited 34

Clinical Trial Overview of Teijin Limited 34

ReNeuron Group plc 35

Clinical Trial Overview of ReNeuron Group plc 35

MacroGenics, Inc. 36

Clinical Trial Overview of MacroGenics, Inc. 36

Emergent BioSolutions Inc. 37

Clinical Trial Overview of Emergent BioSolutions Inc. 37

Bayer AG 38

Clinical Trial Overview of Bayer AG 38

Asahi Kasei Corporation 39

Clinical Trial Overview of Asahi Kasei Corporation 39

Clinical Trial Overview of Top Institutes / Government 40

National Institute of Neurological Disorders and Stroke 40

Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 40

U.S. Department of Veterans Affairs 41

Clinical Trial Overview of U.S. Department of Veterans Affairs 41

Assistance Publique – Hopitaux de Paris 42

Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 42

University of Miami 43

Clinical Trial Overview of University of Miami 43

University of Florida 44

Clinical Trial Overview of University of Florida 44

National Cancer Institute 45

Clinical Trial Overview of National Cancer Institute 45

Hadassah Medical Organization 46

Clinical Trial Overview of Hadassah Medical Organization 46

Medical University of Vienna 47

Clinical Trial Overview of Medical University of Vienna 47

Rouen University Hospital 48

Clinical Trial Overview of Rouen University Hospital 48

Imperial College London 49

Clinical Trial Overview of Imperial College London 49

Five Key Clinical Profiles 50

Appendix 74

Abbreviations 74

Definitions 74

Research Methodology 75

Secondary Research 75

About GlobalData 76

Contact Us 76

Disclaimer 76

Source 76

List of Tables

Paralysis Therapeutics, Global, Clinical Trials by Region, 2014* 7

Paralysis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8

Paralysis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9

Paralysis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10

Paralysis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11

Paralysis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12

Paralysis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13

Paralysis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14

Proportion of Paralysis to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15

Paralysis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16

Paralysis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17

Proportion of Paralysis to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18

Paralysis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19

Paralysis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20

Paralysis Therapeutics, Global, Clinical Trials by Phase, 2014* 21

Paralysis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22

Paralysis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23

Paralysis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24

Paralysis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25

Paralysis Therapeutics, Global, Terminated Clinical Trials, 2014* 26

Paralysis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27

Paralysis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28

Paralysis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29

Paralysis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30

Paralysis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31

Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Stemedica Cell Technologies, Inc., 2014* 32

Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2014* 33

Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Teijin Limited, 2014* 34

Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by ReNeuron Group plc, 2014* 35

Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by MacroGenics, Inc., 2014* 36

Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Emergent BioSolutions Inc., 2014* 37

Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 38

Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Asahi Kasei Corporation, 2014* 39

Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 40

Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 41

Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique – Hopitaux de Paris, 2014* 42

Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2014* 43

Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2014* 44

Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 45

Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014* 46

Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014* 47

Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rouen University Hospital, 2014* 48

Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2014* 49

List of Figures

Paralysis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7

Paralysis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8

Paralysis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9

Paralysis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10

Paralysis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11

Paralysis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12

Paralysis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13

Paralysis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14

Proportion of Paralysis to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15

Paralysis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16

Paralysis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17

Proportion of Paralysis to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18

Paralysis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19

Paralysis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20

Paralysis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21

Paralysis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22

Paralysis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23

Paralysis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24

Paralysis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27

Paralysis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28

Paralysis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29

Paralysis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30

Paralysis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31

GlobalData Methodology 75

Get Updates

Share This Post

Latest Reports from Life Sciences category

© 2014 MarketOptimizer.org. All rights reserved.